Condition: Solid Tumor, Adult · Sponsor: Erasmus Medical Center
This is a proof-of-principle study, that uses freshly resected human solid tumor specimens to assess the performance of topically applied fluorescent imaging agents for the detection of tumor tissue and close / tumor-positive resection margins ex vivo. Surgery will be performed in conformity with hospital protocol. The study will not interfere with the standard clinical care.
This description comes directly from the study's public registry record.
Stijn Keereweer, Dr · 0107041357 · s.keereweer@erasmusmc.nl
Bo Zweedijk, Drs · 0107042985 · b.zweedijk@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Erasmus University Medical Center | Rotterdam, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06292845